Cipla launches needle-free inhalable insulin Afrezza in India
Afrezza comes in single-use cartridges, delivered via a simple inhaler device. Users select the appropriate cartridge, load it, inhale the insulin, and remove the cartridge
Afrezza comes in single-use cartridges, delivered via a simple inhaler device. Users select the appropriate cartridge, load it, inhale the insulin, and remove the cartridge
MRI is particularly valuable in pediatric care due to its non-invasive nature
AEF0217 is a first-in-class CB1 receptor signaling-specific inhibitor
The study, titled “A Large-Scale Efficacy Trial of a Resilience Training Program for First Responders,” will enroll 800 first responders in New York and Texas
The initiative aims to connect startups and tech companies with its business units,
AI-powered cardiometabolic wellness platform for India’s workforce
Anti-microtubule binding region-tau antibody being investigated as a potential disease-modifying therapy to slow or delay progression of disease
Health leaders rally for a national awakening on prevention, mental wellness, and lifestyle reform at ‘Illness to Wellness’ heart care conference
The survey revealed that the proportion of individuals experiencing constant thoughts about food throughout the day declined by 46 percent after starting Wegovy
The first project will focus on developing an AI-based platform for the sterically guided design of bispecific antibodies
Subscribe To Our Newsletter & Stay Updated